Combined BubR1 protein down-regulation and RASSF1A hypermethylation in Wilms tumors with diverse cytogenetic changes

Molecular Carcinogenesis

Volumn 47, Issue 9, 2008, Pages 660-666

  Haruta, Masayuki ^a   Matsumoto, Yoshiyuki ^b   Izumi, Hideki ^b   Watanabe, Naoki ^a   Fukuzawa, Masahiro ^c   Matsuura, Shinya ^b   Kaneko, Yasuhiko ^a,c  

^a SAITAMA CANCER CENTER   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Japan Wilms Tumor Study Group JWiTS   (Japan)

Author keywords

BUB1B; BubR1 protein expression; Chromosome changes; RASSF1A hypermethylation; Wilms tumor

Indexed keywords

BUB1 RELATED PROTEIN; MESSENGER RNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADOLESCENT; ARTICLE; BUB1B GENE; CHILD; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE; HUMAN; HUMAN TISSUE; INFANT; NEPHROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RASSF1A GENE; SEQUENCE ALIGNMENT;

CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; DIPLOIDY; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; METHYLATION; MUTATION; NUCLEIC ACID HYBRIDIZATION; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

EID: 50249095737     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20412     Document Type: Article

References (34)

1. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-785.
2. Michel LS, Liberal V, Chatterjee A, et al. MAD2 haploinsufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001;409:355-359.
3. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 2003;160:341-353.
4. Dai W, Wang Q, Liu T, et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 2004;64:440-445.
5. Iwanaga Y, Chi YH, Miyazato A, et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res 2007;67:160-166.
6. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65:3497-3508.
7. Song MS, Song SJ, Ayad NG, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004;6:129-137.
8. Ehrlich M, Jiang G, Fiala E, et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 2002; 21:6694-6702.
9. Wagner KJ, Cooper WN, Grundy RG, et al. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 2002;21:7277-7282.
10. Kajii T, Ikeuchi T, Yang ZQ, et al. Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: Report of five infants. Am J Med Genet 2001;104:57-64.
11. Hanks S, Coleman K, Reid S, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 2004;36:1159-1161.
12. Matsuura S, Matsumoto Y, Morishima K, et al. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome. Am J Med Genet A 2006;140:358-367.
13. Ikeuchi T, Yoshida M, Oda S, et al. Cytogenetic changes in tumor cells of patients with premature chromatid separation (PCS) syndrome, presented at 49th annual meeting of the Japan society of human genetics, Tokyo, Japan: In abstract; 2004. p 126.
14. Nakadate H, Tsuchiya T, Maseki N, et al. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor. Genes Chromosomes Cancer 1999;25:26-232.
15. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: Results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-1948.
16. Kumon K, Kobayashi H, Namiki T, et al. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: Cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res 2001;92:854-862.
17. Yuan B, Xu Y, Woo JH, et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 2006;12:405-410.
18. Sugawara W, Haruta M, Watanabe N, Tsunematsu Y, Kikuta A, Kaneko Y. Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma. Pediatr Blood Cancer 2007;49:240-249.
19. Schmiemann V, Bocking A, Kazimirek M, et al. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study. Clin Cancer Res 2005;11:7728-7734.
20. Hoque MO, Begum S, Topaloglu O, et al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. J Natl Cancer Inst 2006;98:996-1004.
21. Hanks S, Coleman K, Summersgill B, et al. Comparative genomic hybridization and BUB1B mutation analyses in childhood cancers associated with mosaic variegated aneuploidy syndrome. Cancer Lett 2006;239:234-238.
22. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - A mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;2:107-116.
23. Shichiri M, Yoshinaga K, Hisatomi H, Sugihara K, Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res 2002;62:13-17.
24. Davenport JW, Fernandes ER, Harris LD, Neale GA, Goorha R. The mouse mitotic checkpoin gne bub1b, a novel bub1 family member, is expressed in a cell cycle-dependent manner. Genomics 1999;55:113-117.
25. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
26. King EMJ, van der Sar SJ, Hardwick KG. Mad3 KEN boxes mediate both Cdc20 and Mad3 turnover, and are critical for the spindle checkpoint. PLoS ONE 2007;4:e342 (1-12).
27. Rao CV, Yang YM, Swamy MV, et al. Colonic tumorigenesis in BubR1+/-ApcMin+/- compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci USA 2005;102:4365-4370.
28. Fang Y, Liu T, Wang X, et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 2006;25:3598-3605.
29. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: Lessons from animal models. Oncogene 2001;20:5572-5579.
30. Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP. Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 2003;22:8125-8136.
31. Vos MD, Martinez A, Elam C, et al. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. Cancer Res 2004;64:4244-4250.
32. Hesson L, Bieche I, Krex D, et al. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 2004;23:2408-2419.
33. Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002;21:4345-4349.
34. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-319.